21st Annual Industry/Academia Precision Oncology & Radmed Symposium (Inhibrx 21st Annual Precision Oncology DR5 Agonist Clinical Data Nov25)

Inhibrx Biosciences Inc. published this content on November 05, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 05, 2025 at 22:23 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]